Effect of chronic escitalopram versus placebo on personality traits in healthy first-degree relatives of patients with depression: A randomized trial

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Knorr, Ulla ^a,b   Vinberg, Maj ^a   Mortensen, Erik Lykke ^a   Winkel, Per ^b   Gluud, Christian ^b   Wetterslev, Jørn ^b   Gether, Ulrik ^b   Kessing, Lars Vedel ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESCITALOPRAM; PLACEBO; ANTIDEPRESSANT AGENT; CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; BEHAVIOR; CHRONIC DRUG ADMINISTRATION; CONSCIENTIOUSNESS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; EXTRAVERSION; EYSENCK PERSONALITY QUESTIONNAIRE; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NEUROSIS; NEUROTICISM EXTROVERSION OPENNESS PERSONALITY INVENTORY; OUTCOME ASSESSMENT; PARALLEL DESIGN; PATIENT COMPLIANCE; PERSONALITY; PSYCHOLOGIC TEST; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RELATIVE; SCORING SYSTEM; SELF REPORT; SINGLE BLIND PROCEDURE; SYMPTOM; TREATMENT DURATION; TREND STUDY; ADOLESCENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; EMOTION; FAMILY HEALTH; MIDDLE AGED; PERSONALITY TEST; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; EMOTIONS; FAMILY HEALTH; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROTIC DISORDERS; PERSONALITY; PERSONALITY INVENTORY; PLACEBOS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 84857734141     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031980     Document Type: Article

References (35)

1. Kendler KS, Gatz M, Gardner CO, Pedersen NL, (2006) Personality and major depression: a Swedish longitudinal, population-based twin study. Arch Gen Psychiatry 63: 1113-1120.
2. Kendler KS, Myers J, (2010) The genetic and environmental relationship between major depression and the five-factor model of personality. Psychol Med 40: 801-806.
3. Huezo-Diaz P, Tandon K, Aitchison KJ, (2005) The genetics of depression and related traits. Curr Psychiatry Rep 7: 117-124.
4. Tang TZ, DeRubeis RJ, Hollon SD, Amsterdam J, Shelton R, et al. (2009) Personality change during depression treatment: a placebo-controlled trial. Arch Gen Psychiatry 2009, 66: 1322-1330.
5. Quitkin FM, (1999) Placebos, drug effects, and study design: a clinician's guide. Am J Psychiatry 156: 829-836.
6. Takano A, Arakawa R, Hayashi M, Takahashi H, Ito H, et al. (2007) Relationship between neuroticism personality trait and serotonin transporter binding. Biol Psychiatry 62: 588-592.
7. Frokjaer VG, Vinberg M, Erritzoe D, Svarer C, Baare W, et al. (2009) High familial risk for mood disorder is associated with low dorsolateral prefrontal cortex serotonin transporter binding. Neuroimage 46: 360-366.
8. Knutson B, Wolkowitz OM, Cole SW, Chan T, Moore EA, et al. (1998) Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry 155: 373-379.
9. Tse WS, Bond AJ, (2001) Serotonergic involvement in the psychosocial dimension of personality. J Psychopharmacol 15: 195-198.
10. Arce E, Simmons AN, Lovero KL, Stein MB, Paulus MP, (2008) Escitalopram effects on insula and amygdala BOLD activation during emotional processing. Psychopharmacology (Berl) 196: 661-672.
11. Harmer CJ, Mackay CE, Reid CB, Cowen PJ, Goodwin GM, (2006) Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry 59: 816-820.
12. Nemoto H, Toda H, Nakajima T, Hosokawa S, Okada Y, et al. (2003) Fluvoxamine modulates pain sensation and affective processing of pain in human brain. Neuroreport 14: 791-797.
13. Tse WS, Bond AJ, (2002) Serotonergic intervention affects both social dominance and affiliative behaviour. Psychopharmacology (Berl) 161: 324-330.
14. Rothen S, Vandeleur CL, Lustenberger Y, Jeanpretre N, Ayer E, et al. (2009) Personality traits in children of parents with unipolar and bipolar mood disorders. J Affect Disord 113: 133-141.
15. Christensen MV, Kessing LV, (2006) Do personality traits predict first onset in depressive and bipolar disorder? Nord J Psychiatry 60: 79-88.
16. Knorr U, Kessing LV, (2010) The effect of selective serotonin reuptake inhibitors in healthy subjects. A systematic review. Nord J Psychiatry 64: 153-163.
17. Knorr U, Vinberg M, Klose M, Feldt-Rasmussen U, Hilsted L, et al. (2009) Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram versus placebo on the combined dexamethasone-corticotrophine releasing hormone test and other potential endophenotypes in healthy first-degree relatives of persons with depression. Trials 10: 66.
18. Knorr U, Vinberg M, Hansen A, Klose M, Feldt-Rasmussen U, et al. (2011) Escitalopram and neuroendocrine response in healthy first-degree relatives to depressed patients- a randomized placebo-controlled trial. PLoS One 6: e2124.
19. Knorr U, Vinberg M, Gade A, Winkel P, Gluud C, et al. (2011) A randomised trial of the effect of escitalopram versus placebo on cognitive function in healthy first-degree relatives of patients with depression. Ther Adv Psychopharmacol 1: 133-144.
20. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, et al. (1990): SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 47: 589-593.
21. Wood L, Egger M, Gluud LL, Schulz KF, Juni P, et al. (2008) Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 336: 601-605.
22. Bech P, Kastrup M, Rafaelsen OJ, (1986) Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand Suppl 326: 1-37.
23. Beck AT, Ward CH, Mendelson M, Mock J, Eebauch J, (1961) An inventory for measuring depression. Arch Gen Psychiatry 4: 561-571.
24. Lindstrom E, Lewander T, Malm U, Malt UF, Lublin H, et al. (2001) Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat). Nord J Psychiatry 55 (Suppl 44): 5-69.
25. Skovdahl-Hansen H, (2004) Dokumentation for den danske udgave af NEO-PI-R og NEO-PI-R Kort Version. Copenhagen, Denmark, Dansk Psykologisk Forlag. Ref Type: Report.
26. Eysenck HJ, Eysenck SGB, (1975) The Manual of the Eysenck Personality Questionnaire London Hodder and Stoughton.
27. Costa PT Jr, McCrae RR, (1997) Stability and change in personality assessment: the revised NEO Personality Inventory in the year 2000. J Pers Assess 68: 86-94.
28. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R, (2008) Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 358: 252-260.
29. Barnett JH, Huang J, Perlis RH, Young MM, Rosenbaum JF, et al. (2011) Personality and bipolar disorder: dissecting state and trait associations between mood and personality. Psychol Med 41: 1593-1604.
30. Bech P, Andersen HF, Wade A, (2006) Effective dose of escitalopram in moderate versus severe DSM-IV major depression. Pharmacopsychiatry 39: 128-134.
31. Quilty LC, Meusel LA, Bagby RM, (2006) Neuroticism as a mediator of treatment response to SSRIs in major depressive disorder. J Affect Disord 111: 67-73.
32. Di SM, Norbury R, Harmer CJ, (2011) Short-term antidepressant administration reduces negative self-referential processing in the medial prefrontal cortex in subjects at risk for depression. Mol Psychiatry Epub ahead of print.
33. Harmer CJ, Goodwin GM, Cowen PJ, (2009) Why do antidepressants take so long to work? A cognitive neuropsychological model of antidepressant drug action. Br J Psychiatry 195: 102-108.
34. Du L, Bakish D, Ravindran AV, Hrdina PD, (2002) Does fluoxetine influence major depression by modifying five-factor personality traits? J Affect Disord 71: 235-241.
35. Ekselius L, von KL, (1999) Changes in personality traits during treatment with sertraline or citalopram. Br J Psychiatry 174: 444-448.